CID 101944491

Irbesartan metabolite 1

Structural Information

Molecular Formula
C25H28N6O3
SMILES
CC(CCC1=NC2(CCC(C2)O)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)O
InChI
InChI=1S/C25H28N6O3/c1-16(32)6-11-22-26-25(13-12-19(33)14-25)24(34)31(22)15-17-7-9-18(10-8-17)20-4-2-3-5-21(20)23-27-29-30-28-23/h2-5,7-10,16,19,32-33H,6,11-15H2,1H3,(H,27,28,29,30)
InChIKey
LIDZWACDVHJFLD-UHFFFAOYSA-N
Compound name
8-hydroxy-2-(3-hydroxybutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

460.2223 Da
Monoisotopic Mass

1.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 461.22958 206.7
[M+Na]+ 483.21152 212.5
[M-H]- 459.21502 212.2
[M+NH4]+ 478.25612 212.0
[M+K]+ 499.18546 205.5
[M+H-H2O]+ 443.21956 195.3
[M+HCOO]- 505.22050 216.9
[M+CH3COO]- 519.23615 212.6
[M+Na-2H]- 481.19697 200.0
[M]+ 460.22175 204.1
[M]- 460.22285 204.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.